Market Cap 5.27B
Revenue (ttm) 3.70B
Net Income (ttm) 280.09M
EPS (ttm) N/A
PE Ratio 19.62
Forward PE 19.97
Profit Margin 7.57%
Debt to Equity Ratio 0.29
Volume 265,500
Avg Vol 378,792
Day's Range N/A - N/A
Shares Out 30.88M
Stochastic %K 95%
Beta 0.11
Analysts Sell
Price Target $166.00

Company Profile

FTI Consulting, Inc. provides business advisory services to manage change, mitigate risk, and resolve disputes worldwide. The company operates through Corporate Finance & Restructuring; Forensic and Litigation Consulting; Economic Consulting; and Technology, and Strategic Communications segments. The Corporate Finance & Restructuring segment provides business transformation and strategy, transactions, and turnaround and restructuring services. The Forensic and Litigation Consulting segment offer...

Industry: Consulting Services
Sector: Industrials
Phone: 202 312 9100
Fax: 202 312 9101
Address:
555 12th Street NW, Suite 700, Washington, United States
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 13 at 8:46 PM
$FCN $LMDX $NDAQ $RHHBY $SPY @Geo1313 DID YOU 👁️👁️ THIS?!
1 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 13 at 5:53 PM
$FCN $LMDX $NDAQ $RHHBY $SPY Still….. https://x.com/lmdxtruthseeker/status/1999733628146975149?s=46
0 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 13 at 3:38 AM
$LMDX $RHHBY $SPY $NDAQ $FCN What in the 🌎 is going on here. 👁️👁️
0 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 12 at 6:30 PM
$FCN $LMDX $NDAQ $RHHBY $SPY Wonder what will Happening? 🤔
0 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 12 at 6:31 AM
$LMDX $RHHBY $FCN $SPY $NDAQ https://x.com/lmdxtruthseeker/status/1998674857140138122?s=46
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:15 AM
Actionable Trade Alert for $FCN: Market Context: The last close for $FCN was $168.39, indicating a bullish sentiment as it is above the 30-day (MA30) and 50-day (MA50) moving averages. The RSI at 62.57 suggests that the stock is nearing overbought territory but still has room to run. Directional Bias: With the price above both MAs and close to the 60-day high of $170.98, there is a positive momentum. The ATR of 3.65 indicates volatility, allowing for potential price movement. Trade Plan: - Suggested Entry: $168.50 - Stop Loss: $165.00 (3.5% below entry) - Take Profit Targets: 1. $172.00 (2.2% gain) 2. $175.00 (3.9% gain) 3. $197.00 (16.9% gain) Rationale: Target 3 provides a potential ROI of 17% or more, capitalizing on the upward momentum while managing risk with a stop loss. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:18 AM
Actionable Trade Alert for $FCN: Market Context: $FCN is currently trading at $166.6, showing strength as it approaches the 60D high of $170.98. The RSI of 59.71 indicates bullish momentum but is not overbought, suggesting room for upward movement. The MA30 at $165.03 and MA50 at $162.24 provide solid support levels. Directional Bias: The price is above both the MA30 and MA50, indicating a bullish trend. With the recent high of $170.98, we have a clear target to aim for. Trade Plan: - Suggested Entry: $167.00 - Stop Loss: $162.00 (approximately 3% below entry) - Take Profit Targets: 1. TP1: $170.00 (2% gain) 2. TP2: $173.00 (3.6% gain) 3. TP3: $195.00 (16.9% gain) This trade plan offers a potential ROI of over 17% at TP3 while maintaining a manageable risk. Monitor the trade closely for any changes in momentum. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 9 at 7:12 PM
$FCN Current Stock Price: $166.46 Contracts to trade: $165 FCN Dec 19 2025 Call Entry: $2.60 Exit: $4.28 ROI: 64% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 9 at 12:07 AM
Actionable Trade Alert for $FCN: Market Context: $FCN is currently trading at $165.01, showing a stable position within its recent range. The RSI at 57.06 indicates bullish momentum, suggesting potential for upward movement. The 30-day moving average (MA30) aligns with the current price, indicating support, while the 50-day moving average (MA50) at $162.12 provides additional bullish confirmation. Directional Bias: With the price above the MA50 and the RSI indicating strength, the bias is bullish. The recent high of $170.98 provides a target for potential gains, while the low of $149.31 suggests a solid risk management level. Trade Plan: - Suggested Entry: $165.50 - Stop Loss: $161.50 (3% below entry) - Take Profit Targets: 1. $170.00 (Target 1, 2.26% gain) 2. $173.00 (Target 2, 4.52% gain) 3. $193.00 (Target 3, 17% gain) This plan offers a favorable risk-reward ratio with a potential 17% ROI on the third target. https://privateprofiteers.com
0 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 7 at 10:11 PM
$LMDX $RHHBY $FCN At this point, regulatory intervention is the only mechanism capable of forcing transparency, recovering diverted assets, or holding insiders accountable. Everything else is a waste of time in my opinion. ✌️
0 · Reply
Latest News on FCN
FTI Consulting (FCN) Q3 2025 Earnings Transcript

Oct 23, 2025, 1:01 PM EDT - 7 weeks ago

FTI Consulting (FCN) Q3 2025 Earnings Transcript


FTI Consulting, Inc. (FCN) Q3 2025 Earnings Call Transcript

Oct 23, 2025, 12:47 PM EDT - 7 weeks ago

FTI Consulting, Inc. (FCN) Q3 2025 Earnings Call Transcript


FTI Consulting Announces CFO Transition

Aug 12, 2025, 7:00 AM EDT - 4 months ago

FTI Consulting Announces CFO Transition


FTI Consulting Tops Q2 Estimates

Jul 25, 2025, 7:22 PM EDT - 5 months ago

FTI Consulting Tops Q2 Estimates


FTI Consulting, Inc. (FCN) Q2 2025 Earnings Call Transcript

Jul 24, 2025, 2:22 PM EDT - 5 months ago

FTI Consulting, Inc. (FCN) Q2 2025 Earnings Call Transcript


FTI Consulting FCN Q2 2025 Earnings Transcript

Jul 24, 2025, 10:19 AM EDT - 5 months ago

FTI Consulting FCN Q2 2025 Earnings Transcript


FTI Consulting Reports Second Quarter 2025 Financial Results

Jul 24, 2025, 7:30 AM EDT - 5 months ago

FTI Consulting Reports Second Quarter 2025 Financial Results


FTI Consulting: A Hidden Gem or Just Fine?

Jun 3, 2025, 7:00 PM EDT - 6 months ago

FTI Consulting: A Hidden Gem or Just Fine?


FTI Consulting Announces Technology Alliance with BigID

May 20, 2025, 7:30 AM EDT - 7 months ago

FTI Consulting Announces Technology Alliance with BigID


lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 13 at 8:46 PM
$FCN $LMDX $NDAQ $RHHBY $SPY @Geo1313 DID YOU 👁️👁️ THIS?!
1 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 13 at 5:53 PM
$FCN $LMDX $NDAQ $RHHBY $SPY Still….. https://x.com/lmdxtruthseeker/status/1999733628146975149?s=46
0 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 13 at 3:38 AM
$LMDX $RHHBY $SPY $NDAQ $FCN What in the 🌎 is going on here. 👁️👁️
0 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 12 at 6:30 PM
$FCN $LMDX $NDAQ $RHHBY $SPY Wonder what will Happening? 🤔
0 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 12 at 6:31 AM
$LMDX $RHHBY $FCN $SPY $NDAQ https://x.com/lmdxtruthseeker/status/1998674857140138122?s=46
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:15 AM
Actionable Trade Alert for $FCN: Market Context: The last close for $FCN was $168.39, indicating a bullish sentiment as it is above the 30-day (MA30) and 50-day (MA50) moving averages. The RSI at 62.57 suggests that the stock is nearing overbought territory but still has room to run. Directional Bias: With the price above both MAs and close to the 60-day high of $170.98, there is a positive momentum. The ATR of 3.65 indicates volatility, allowing for potential price movement. Trade Plan: - Suggested Entry: $168.50 - Stop Loss: $165.00 (3.5% below entry) - Take Profit Targets: 1. $172.00 (2.2% gain) 2. $175.00 (3.9% gain) 3. $197.00 (16.9% gain) Rationale: Target 3 provides a potential ROI of 17% or more, capitalizing on the upward momentum while managing risk with a stop loss. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:18 AM
Actionable Trade Alert for $FCN: Market Context: $FCN is currently trading at $166.6, showing strength as it approaches the 60D high of $170.98. The RSI of 59.71 indicates bullish momentum but is not overbought, suggesting room for upward movement. The MA30 at $165.03 and MA50 at $162.24 provide solid support levels. Directional Bias: The price is above both the MA30 and MA50, indicating a bullish trend. With the recent high of $170.98, we have a clear target to aim for. Trade Plan: - Suggested Entry: $167.00 - Stop Loss: $162.00 (approximately 3% below entry) - Take Profit Targets: 1. TP1: $170.00 (2% gain) 2. TP2: $173.00 (3.6% gain) 3. TP3: $195.00 (16.9% gain) This trade plan offers a potential ROI of over 17% at TP3 while maintaining a manageable risk. Monitor the trade closely for any changes in momentum. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 9 at 7:12 PM
$FCN Current Stock Price: $166.46 Contracts to trade: $165 FCN Dec 19 2025 Call Entry: $2.60 Exit: $4.28 ROI: 64% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 9 at 12:07 AM
Actionable Trade Alert for $FCN: Market Context: $FCN is currently trading at $165.01, showing a stable position within its recent range. The RSI at 57.06 indicates bullish momentum, suggesting potential for upward movement. The 30-day moving average (MA30) aligns with the current price, indicating support, while the 50-day moving average (MA50) at $162.12 provides additional bullish confirmation. Directional Bias: With the price above the MA50 and the RSI indicating strength, the bias is bullish. The recent high of $170.98 provides a target for potential gains, while the low of $149.31 suggests a solid risk management level. Trade Plan: - Suggested Entry: $165.50 - Stop Loss: $161.50 (3% below entry) - Take Profit Targets: 1. $170.00 (Target 1, 2.26% gain) 2. $173.00 (Target 2, 4.52% gain) 3. $193.00 (Target 3, 17% gain) This plan offers a favorable risk-reward ratio with a potential 17% ROI on the third target. https://privateprofiteers.com
0 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 7 at 10:11 PM
$LMDX $RHHBY $FCN At this point, regulatory intervention is the only mechanism capable of forcing transparency, recovering diverted assets, or holding insiders accountable. Everything else is a waste of time in my opinion. ✌️
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Dec. 6 at 4:32 AM
Comparing trending tickers $FIX vs $FCN: FIX dipped slightly by 0.32% to $1001.48 with a trading volume of 378.1K shares, a bit below its average of 447.2K. On the other hand, FCN saw a notable increase of 2.48%, reaching $170.79, with a volume of 337.7K shares, also slightly under its average volume of 361.8K. While both stocks are trading under their usual volume, FCN is demonstrating stronger positive momentum in its price compared to the slight decline observed in FIX.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:06 AM
Actionable Trade Alert for $FCN: Market Context: $FCN closed at $166.66, showing stability above the MA30 (164.21) and MA50 (161.85). The RSI at 54.27 indicates a neutral to slightly bullish sentiment, suggesting potential upward momentum. Directional Bias: The current price is near the 60D high of 170.98, providing a resistance level. The RSI indicates no overbought conditions, allowing for further upside potential. The price is also well above the 60D low of 149.31, indicating a bullish trend in the short term. Trade Plan: - Suggested Entry: $167.00 (slightly above the last close to confirm momentum) - Stop Loss: $163.00 (below MA30 for safety) - Take Profit Targets: 1. $171.00 (2% gain) 2. $175.00 (4.9% gain) 3. $195.00 (17% gain) This plan leverages current momentum while maintaining a solid risk-reward ratio. https://privateprofiteers.com
0 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 6 at 12:20 AM
$FCN $LMDX $RHHBY $SPY The result is that sophisticated intangible assets — previously integrated into LumiraDx’s diagnostics ecosystem — were removed from the balance sheet without transparency, allowing insiders to reposition them elsewhere while the parent company collapsed. That is materially different from “cutting costs.” It is the quiet removal of an operational asset under the guise of restructuring, leaving investors with the impression that expenses were reduced, when in reality a distinct piece of the business was separated and preserved outside the insolvency process.
0 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 6 at 12:19 AM
$FCN $LMDX $RHHBY $SPY By treating the removal of Invita as an operating expense reduction rather than a transfer of assets, management avoided acknowledging that a functional digital platform — with software, data infrastructure, IP, contracts, and operational know-how — had been carved out of the corporate estate. That allowed them to present the restructuring as routine efficiency improvements instead of admitting that a potentially valuable technology business was extracted before creditors and shareholders could even evaluate it. The lack of disclosure also prevented any fair-market valuation, independent appraisal, or competitive bidding that would normally be required if a core platform were legitimately divested.
0 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 6 at 12:19 AM
$FCN $LMDX $RHHBY $SPY $FCN $LMDX $RHHBY $SPY Electradx Tauns LumiraDx portrayed the disappearance of Invita as nothing more than “cost cutting,” but that narrative does not hold up under scrutiny. Invita did not show up as an asset sale, a divestiture, an impairment, or a related-party transaction in any SEC filing or liquidation summary. It was not accounted for as a discontinued operation or a write-down. It wasn’t moved through a disclosed sale process. It simply vanished from the financial statements and appeared later as a stand-alone entity under new ownership and new directorship, including individuals who were previously inside the LumiraDx ecosystem.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:41 PM
Actionable Trade Alert for $FCN: Market Context: $FCN closed at $166.66, showing stability above the MA30 (164.21) and MA50 (161.85). The RSI at 54.27 indicates a neutral to slightly bullish sentiment, suggesting potential upward momentum. Directional Bias: The current price is near the 60D high of 170.98, providing a resistance level. The RSI indicates no overbought conditions, allowing for further upside potential. The price is also well above the 60D low of 149.31, indicating a bullish trend in the short term. Trade Plan: - Suggested Entry: $167.00 (slightly above the last close to confirm momentum) - Stop Loss: $163.00 (below MA30 for safety) - Take Profit Targets: 1. $171.00 (2% gain) 2. $175.00 (4.9% gain) 3. $195.00 (17% gain) This plan leverages current momentum while maintaining a solid risk-reward ratio. https://privateprofiteers.com
0 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 5 at 1:42 AM
$LMDX @PagPag $FCN What makes most sense based on their actions LumiraDx may have created the pre-/post-February share distinction to block new OTC buyers from gaining voting rights or legal standing during the collapse. Once the stock moved OTC, anyone could cheaply accumulate a large position and potentially challenge the liquidation, asset transfers, or insider dealings. By fixing a cutoff date, LMDX could argue that only pre-February shareholders had any voting rights or governance claims, while all later buyers had none. This would protect insiders during the wind-down (their master plan after invita) and prevent activist shareholders from interfering with the dissolution, IP movements, or the Roche transaction. Keeping all to themselves. Completely Shameful. In my opinion this needs to be investigated deeply cause the ones that over saw everything seemed to miss allot or were taken care of.
1 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 4 at 11:52 PM
$FCN $LMDX $RHHBY $SPY Electradx Tauns LumiraDx made it look like they were just “cutting costs” when Invita vanished from the books, but that’s not what actually happened in my opinion. It wasn’t disclosed as an asset sale, an impairment, or a related-party transfer — it simply disappeared. That let management frame it as routine cost reduction instead of admitting that valuable digital assets and technology had been moved out of the estate altogether.
0 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 4 at 11:36 PM
$LMDX $LMDX $FCN $LMDX $RHHBY $SPY $ELECTRADX $TAUN The continuity of personnel and capabilities, combined with Invita’s disappearance from LumiraDx’s asset disclosures and the complete lack of any impairment, divestiture, or valuation explanation, strongly indicates that material corporate value may have been moved outside the reach of creditors and shareholders before insolvency. The timing of the separation, the sudden balance-sheet collapse, the re-aggregation of insiders at ElectraDx, the absence of transparent reporting on any asset transfers, and the failure to account for high-value digital IP all point to a single conclusion: shareholders were likely deprived of assets that should have remained within the LumiraDx estate. If confirmed, this would represent serious breaches of fiduciary duty, potential fraudulent conveyance, and materially misleading financial reporting. To me it’s clear as day.
1 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 4 at 3:55 AM
$FCN $LMDX $RHHBY $SPY Part 3 If proven, this may constitute: • fraudulent transfer (moving value out of reach of stakeholders) • breach of fiduciary duty (self-dealing, failing to maximize value) • market misrepresentation (omitting material assets and conflicts) • pre-pack phoenixing (continuing the enterprise through new entities) • insolvency abuse (undervalue transactions and director misfeasance)
0 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 4 at 3:54 AM
$FCN $LMDX $RHHBY $SPY Part 2 Shareholders received nothing because the insiders structured the process as an asset sale, not a company sale. Executives resigned at critical moments, reappeared in successor companies, and controlled the wind-down while holding shares, options, or conflicts of interest. Key pipeline assets (especially the TB test) were never independently valued, never disclosed properly, and never included in the sale consideration. This has the hallmarks of a coordinated scheme in which insiders: • declared insolvency while still holding valuable undeclared assets • transferred or shielded IP and operating capabilities • sold core assets to Roche at an undervalued price • preserved continuity in new entities they controlled • left shareholders with a hollow shell and zero recovery
0 · Reply
lmdxxxxxxxxxx
lmdxxxxxxxxxx Dec. 4 at 3:53 AM
$LMDX $FCN $RHHBY $SPY $ELECTRADX $TAUN What my research tells me… Part 1 LumiraDx’s collapse was not a normal insolvency. The company’s valuable assets—its POC platform, TB test, SureSensors biosensor IP, Invita software/data, manufacturing know-how, and scientific talent—were quietly split, withheld, or redirected before and during the liquidation process. Roche acquired the commercial POC assets cheaply, while other high-value components resurfaced in spinouts and successor entities tied to former LMDX insiders (Invita/IVD Intelligence, ElectraDx, SureSensors continuity, LKM).
0 · Reply